RecruitingNCT04203979
Sepsis: From Syndrome to Personalized Care
Sponsor
Oslo University Hospital
Enrollment
1,950 participants
Start Date
Jan 6, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective, observational study designed to examine the performance of biomarkers, molecular biological methods and other analysis in blood from patient with suspected sepsis in the Emergency department, as well as identidying novel sepsis endotypes. Around 1500 patients will be enrolled.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- admitted to emergency department OUH, Ullevål.
- managed by the medical rapid response team or the sepsis rapid response team
Exclusion Criteria1
- Not given informed consent by patient or next of kin (if patient is not able to)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04203979
Related Trials
Febrile Infants Swedish Study
NCT0713475111 locations
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT0717927623 locations
The PvCO2-PaCO2/CaO2-CvO2 Ratio in Septic Shock
NCT070962843 locations
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
NCT039923781 location
Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients
NCT0614014722 locations